Does TOFACITINIB Cause Injection site induration? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Injection site induration have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.0% of all adverse event reports for TOFACITINIB.
11
Reports of Injection site induration with TOFACITINIB
0.0%
of all TOFACITINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site induration From TOFACITINIB?
Of the 11 reports, 3 (27.3%) required hospitalization.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
IXEKIZUMAB (177)
Which TOFACITINIB Alternatives Have Lower Injection site induration Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN